Analystreport

DiaMedica Therapeutics Inc. (NASDAQ: DMAC) had its price target raised by analysts at Craig Hallum from $15.00 to $20.00.

DiaMedica Therapeutics Inc.  (DMAC) 
Last diamedica therapeutics inc. earnings: 11/13 04:12 pm Check Earnings Report